These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23317492)

  • 1. Giant basal cell carcinoma. Improvement and vitiligo-like hypopigmentation after intermittent treatment with 5% imiquimod.
    Urbina F
    Acta Dermatovenerol Croat; 2012; 20(4):275-8. PubMed ID: 23317492
    [No Abstract]   [Full Text] [Related]  

  • 2. Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma.
    Gowda S; Tillman DK; Fitzpatrick JE; Gaspari AA; Goldenberg G
    J Cutan Pathol; 2009 Aug; 36(8):878-81. PubMed ID: 19586497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma.
    Sriprakash K; Godbolt A
    Australas J Dermatol; 2009 Aug; 50(3):211-3. PubMed ID: 19659986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitiligo-like hypopigmentation with poliosis following treatment of superficial basal cell carcinoma with imiquimod.
    Jacob SE; Blyumin M
    Dermatol Surg; 2008 Jun; 34(6):844-5. PubMed ID: 18363730
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of multiple basal cell carcinomas in the scalp with imiquimod 5% cream.
    Hannuksela-Svahn A; Nordal E; Christensen OB
    Acta Derm Venereol; 2000; 80(5):381-2. PubMed ID: 11200841
    [No Abstract]   [Full Text] [Related]  

  • 6. Imiquimod-induced depigmentation: report of two cases and review of the literature.
    Burnett CT; Kouba DJ
    Dermatol Surg; 2012 Nov; 38(11):1872-5. PubMed ID: 22805097
    [No Abstract]   [Full Text] [Related]  

  • 7. Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure.
    Harting M; Vujevich J; Goldberg LH
    Dermatol Surg; 2007 Dec; 33(12):1516-9. PubMed ID: 18076623
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod.
    Mashiah J; Brenner S
    Clin Exp Dermatol; 2008 Jan; 33(1):74-6. PubMed ID: 17979992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete basal cell carcinoma remission with imiquimod in a patient with nevoid basal cell carcinoma syndrome and associated basal cell carcinoma of the scalp and invasive ductal breast cancer.
    Quist SR; Franke I; Helmdach M; Kraus C; Reis A; Froster UG; Fehsecke D; Gollnick HP; Bonnekoh B
    J Am Acad Dermatol; 2011 Mar; 64(3):611-3. PubMed ID: 21315966
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod.
    Santiago Sánchez-Mateos D; Goiriz Valdés R; Daudén Tello E
    Clin Exp Dermatol; 2010 Mar; 35(2):199-200. PubMed ID: 19486047
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report.
    Dirschka T; Schmitz L; Bartha Á
    Eur J Dermatol; 2016 Aug; 26(4):408-9. PubMed ID: 27097553
    [No Abstract]   [Full Text] [Related]  

  • 12. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
    Shulstad RM
    Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream.
    Turan A; Saricaoglu H; Baskan EB; Toker SC; Tunali S
    Int J Dermatol; 2009 Feb; 48(2):214-5. PubMed ID: 19200213
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: "Imiquimod 5% cream for the treatment of periocular basal cell carcinoma".
    Pakdel F; Kashkouli MB
    Ophthalmic Plast Reconstr Surg; 2011; 27(4):305; author reply 305-6. PubMed ID: 20966793
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream.
    Plachouri KM; Balasis S; Mallioris AF; Koumoundourou D; Georgiou S
    Dermatol Ther; 2018 Sep; 31(5):e12685. PubMed ID: 30133929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.
    Vereecken P; Monsieur E; Petein M; Heenen M
    J Dermatolog Treat; 2004 Apr; 15(2):120-1. PubMed ID: 15204165
    [No Abstract]   [Full Text] [Related]  

  • 17. [Topical treatment of melanoma skin metastases with imiquimod].
    Sigüenza M; Pizarro A; Mayor M; Vidaurrázaga C; Miralles L; González-Beato M; Casado M
    Actas Dermosifiliogr; 2005 Mar; 96(2):111-5. PubMed ID: 16476347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Rub on' treatment for basal-cell carcinoma.
    Kerr C
    Lancet Oncol; 2002 Apr; 3(4):201. PubMed ID: 12067676
    [No Abstract]   [Full Text] [Related]  

  • 19. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
    Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
    Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas.
    Marks R; Owens M; Walters SA;
    Arch Dermatol; 2004 Oct; 140(10):1284-5. PubMed ID: 15492200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.